Aprea Therapeutics Inc.

APRE | NASDAQ

Price Alert Chart Builder DCF Calculator

$0.74

-$0.02 (-2.62%)

At close: Sep 21, 2026, 4:00 PM ET

$0.80

+$0.06 (+8.11%)

After-hours: Sep 21, 2026, 7:50 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $9.41M

Enterprise Value $-32.11M

Beta 1.63

Average Volume 213.83K

Shares Outstanding (Diluted) 53.48M

Shares Change YoY 779.18%

Institutional Ownership 4.20%

Exchange NASDAQ

ISIN US03836J2015

Price Performance

Price Change 1M 7.3%

Price Change 3M -10.6%

Price Change 6M 10.3%

Price Change YTD -13.3%

Price Change 1Y -49.7%

Price Change 3Y -82.2%

Price Change 5Y -99.2%

1M CAGR (ann.) 20.1%

1Y CAGR (ann.) -49.3%

5Y CAGR (ann.) -61.8%

All-Time CAGR -59.5%

Valuation

PE Ratio -0.57

Forward PE N/A

PEG Ratio -0.01

Forward PEG -0.51

PS Ratio N/A

Forward PS 4.00

PB Ratio 0.24

P/FCF Ratio -0.75

P/Adj. FCF Ratio -0.72

P/OCF Ratio -3.22

EV/Sales N/A

EV/EBIT 2.61

EV/EBITDA 2.61

EV/FCF 2.64

Earnings Yield -174.3%

FCF Yield -133.5%

Adj. FCF Yield -138.2%

Financial Health

Net Cash $41.23M

Total Debt $0

Cash & Short-Term Investments $41.23M

Total Assets $42.29M

Current Ratio 13.55

Quick Ratio 13.55

Debt / Equity Ratio 0.00

Debt / EBITDA -0.00

Debt / FCF -0.00

OCF / Debt N/A

Interest Coverage 0.00

Altman Z-Score -9.65

Piotroski F-Score 3

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -3.5%

Returns

Return on Assets -29.1%

Return on Equity -46.7%

Return on Invested Capital -33.7%

Return on Capital Employed -33.7%

Return on Tangible Assets -29.1%

Historical Growth (CAGR)

Revenue CAGR 3Y -90.4%

Revenue CAGR 5Y 12.5%

Revenue CAGR 10Y N/A

EPS CAGR 3Y 39.3%

EPS CAGR 5Y 55.2%

EPS CAGR 10Y N/A

FCF CAGR 3Y 5.8%

FCF CAGR 5Y 25.7%

FCF CAGR 10Y N/A

Analyst Forecasts

Analyst Rating Buy

Analyst Count 2

EPS Growth Next 3Y 18.4%

Revenue Growth Next 3Y N/A

Earnings Date N/A

EPS Estimate (next Q) N/A

EPS Growth Est (next Q) N/A

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $2.10

Price Target Upside 183.8%

Cash Flow

Operating Cash Flow $-12.17M

Free Cash Flow $-12.18M

Adj. Free Cash Flow $-12.61M

FCF Per Share -$0.23

OCF Per Share -$0.23

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $-5.43K

Operating Income $-13.22M

EBITDA $-12.29M

Net Income $-12.31M

EPS (Diluted) -$1.29

Revenue / Employee N/A

Profit / Employee $-1.54M

Employees 8